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Tricuspid Valve Replacement With Simultaneous
Paravalvular Leak Closure in a Patient With
Refractory Right Heart FailureSerdar Sevimli, MD,* Enbiya Aksakal, MD,* Ibrahim Halil Tanboga, MD,* Engin Bozkurt, MDy
Erzurum and Ankara, TurkeyA 38-year-old male patient presented to our hos-
pital with a 3-month history of shortness of breath
in combination with severe peripheral edema and
ascites. Twenty-two years previously, he had un-
dergone bioprosthetic tricuspid valve implantation
due to Ebstein anomaly. Transthoracic echocardi-
ography revealed signiﬁcantly dilated right cardiac
chambers, reduced right ventricular function, ste-
notic and degenerated bioprosthetic tricuspid valve,
and marked tricuspid insufﬁciency associated
with a 22-mm paravalvular defect located lateral to
the valve (Fig. 1, Online Videos 1, 2, and 3).
Cardiac computed tomography also revealed
signiﬁcantly dilated right cardiac chambers and
a 24-mm defect located lateral to the valve.Figure 1. TV Dysfunction and Paravalvular Leak
Tricuspid bioprosthetic valve (TV) dysfunction and large paravalvular leak
LV ¼ left ventricle; RV ¼ right ventricle.
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they have no relationships relevant to the contents of this paper to disclose.The patient was subjected to intense medical
therapy. However, no remarkable improvement
was observed. During the hospital stay, a total of
30 l of ascitic ﬂuid was collected by paracentesis.
Thus, we decided to treat both dysfunctional bio-
prosthetic valve and severe paravalvular leak with
percutaneous treatment. The patient was admitted
to the catheterization laboratory. First, the bio-
prosthetic tricuspid valve was predilated with a
23-mm balloon (Fig. 2). Thereafter, the bio-
prosthetic tricuspid valve was subjected to trans-
valvular valve-in-valve replacement with a 23-mm
Edwards Sapien heart valve (Edwards Lifesciences,
Irvine, California) (Fig. 3), followed by the closure
of paravalvular leak with 30-mm Amplatzeron transthoracic echocardiography. (See Online Videos 1, 2, and 3.)
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Figure 3. TV Replacement
Transcatheter valve-in-valve replacement with a 23-mm Edwards Sapien
valve. TV ¼ tricuspid valve.
Figure 2. Pre-Dilation of TV
Pre-dilation of bioprosthetic tricuspid valve (TV) with a 23-mm balloon.
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e80occluder device (St. Jude Medical, St. Paul, Minnesota) via
transfemoral vein (Fig. 4, Online Videos 4, 5, and 6). After
the procedure, the severe paravalvular leak was resolved, and
transcatheter tricuspid valve was found to be functional on
transthoracic echocardiography and cardiac computed to-
mography. The patient remained ascites-free during the ﬁrst
month. In conclusion, for the ﬁrst time in the literature, we
successfully applied transcatheter valve-in-valve bio-
prosthetic tricuspid valve replacement and paravalvular leak
closure using Amplatzer occluder device in the same session.
The patient underwent tricuspid valve replacement for
Ebstein anomaly approximately 22 years ago. Bioprosthetic
valve degeneration and paravalvular leak had occurred after
many years. Degeneration of tricuspid valve bioprosthesis is
often encountered in young patients. Although the exact
mechanism for paravalvular leak is not clear, it might be relatedFigure 4. Leak Closure
Paravalvular leak closure with 30-mm Amplatzer occluder device. (See Online Videoto infective endocarditis. We thought that the patient pre-
sented in the late course as the tricuspid regurgitation related
to this pathology might be asymptomatic for many years.
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APPENDIX
For supplemental videos, please see the online version of this article.s 4, 5, and 6.)
